Truveta news For media inquiries, please email news@truveta.com Transparency is the new standard: FDA’s view on regulatory-grade RWE October 3, 2025 Truveta adds new precision device data September 23, 2025 Celebrating 5 years of Saving Lives with Data September 22, 2025 Johns Hopkins builds research community to explore new frontiers in health using Truveta Data September 10, 2025 How Truveta benchmarks AI model quality for clinical concept extraction May 22, 2025 Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers May 8, 2025 Top 5 takeaways from Truveta Symposium 2025 May 6, 2025 Making Americans healthier – with data March 27, 2025 « Previous 1 2 3 … 11 Next » Truveta in the news Children who miss early vaccines more likely to not get the MMR shot by age 2 Women with PCOS seek relief in weight-loss drugs Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says FDA to streamline approvals for generic biological drugs in latest move targeting health costs See all articles Recent press releases Truveta deepens oncology and scientific leadership with appointment of Johnathan Lancaster, MD, PhD as President and Chief Scientific Officer January 26, 2026 Truveta launches Truveta Live Link January 13, 2026 New Truveta research published in JAMA Network Open reveals declining timeliness in childhood MMR vaccination and identifies early predictors of missed immunizations January 2, 2026 Truveta research published in JAMA Network Open shows rapid uptake of early measles vaccination during Texas outbreak November 14, 2025 See all press releases Images Truveta logo Format: PNG Truveta Data Map Format: PNG Truveta Health System Members Format: PNG
Johns Hopkins builds research community to explore new frontiers in health using Truveta Data September 10, 2025
Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers May 8, 2025
Truveta deepens oncology and scientific leadership with appointment of Johnathan Lancaster, MD, PhD as President and Chief Scientific Officer January 26, 2026
New Truveta research published in JAMA Network Open reveals declining timeliness in childhood MMR vaccination and identifies early predictors of missed immunizations January 2, 2026
Truveta research published in JAMA Network Open shows rapid uptake of early measles vaccination during Texas outbreak November 14, 2025